OrphanDrug
OrphanDrug
Pharma Knowledge Base

secondary hypoparathyroidism due to impaired parathormon secretion

ORPHA: 140286

Contents

  1. 1. Overview
  2. 2. Available Treatments
  3. 3. Clinical Presentation
  4. 4. Classification & Codes

Overview

human disease

Available Treatments (0)

No treatments linked yet

Clinical trials or compassionate use may be available — consult a specialist.

Clinical Presentation

Signs and symptoms associated with secondary hypoparathyroidism due to impaired parathormon secretion, sourced from HPO and Orphanet clinical annotations.

Abnormality of the parathyroid glandNephrocalcinosisHypoparathyroidismBasal ganglia calcificationHypocalcemiaHyperphosphatemiaFatigueDecreased circulating parathyroid hormone levelDepressionAnxietySeizureHypercalciuriaFasciculationsRicketsOsteomalaciaMuscle spasmBipolar affective disorderPosterior subcapsular cataractArrhythmiaLaryngospasmAcroparesthesiaChvostek signBrain fogHypoesthesiaBronchoconstrictionTrousseau sign

Classification & Codes

Orphanet Code

ORPHA:140286
secondary hypoparathyroidism due to impaired parathormon secretion
OrphanetORPHA:140286
Treatments0 drug(s)
Symptoms on record26 signs
Statuspublished
Factual Authority
Last Updated3/20/2026
Clinical DataHPO · Orphanet
Drug DataFDA · EMA · CDSCO
secondary hypoparathyroidism due to impaired parathormon secretion | OrphanDrug